Literature DB >> 25908653

Spatial epidemiology of blastomycosis hospitalizations: detecting clusters and identifying environmental risk factors.

Amy E Seitz1, Jennifer Adjemian2, Claudia A Steiner3, D Rebecca Prevots2.   

Abstract

Blastomycosis is a disease caused by endemic fungi that ranges from severe pulmonary or disseminated to mild or asymptomatic. Environmental factors associated with it are not well described throughout the endemic area. We used the intramural State Inpatient Database from the Agency for Healthcare Research and Quality and ArcMap GIS to identify geographic high-risk clusters of blastomycosis hospitalizations in 13 states in the US endemic regions (AR, IA, IL, IN, KY, LA, MI, MN, MO, MS, OH, TN, and WI). We then used logistic regression to identify risk factors associated with these high-risk clusters. We describe six clusters of counties in which there was an elevated incidence of blastomycosis hospitalizations. We identified maximum mean annual temperature, percentage of persons aged ≥65 years, and mercury and copper soil content as being associated with high-risk clusters. Specifically, the odds of a county being part of a high-risk cluster was associated with increasing percentage of population over age 65, decreasing maximum temperature, increasing mercury, and decreasing copper soil content. Healthcare providers should be aware of these high-risk areas so that blastomycosis can be included, as appropriate, in a differential diagnosis for patients currently or previously residing in these areas. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Blastomyces dermatitidis; Blastomyces gilchristii; blastomycosis; epidemiology

Mesh:

Year:  2015        PMID: 25908653     DOI: 10.1093/mmy/myv014

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

1.  Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors:  Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal:  Curr Clin Microbiol Rep       Date:  2016-04-18

2.  Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis.

Authors:  Holly M Frost; Thomas J Novicki
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

3.  Use of Urine Antigen Testing for Blastomyces in an Integrated Health System.

Authors:  Dennis J Baumgardner
Journal:  J Patient Cent Res Rev       Date:  2018-04-26

Review 4.  Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.

Authors:  Pamela P Lee; Yu-Lung Lau
Journal:  Front Immunol       Date:  2017-06-28       Impact factor: 7.561

Review 5.  Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment.

Authors:  Bent-Are Hansen; Øystein Wendelbo; Øyvind Bruserud; Anette Lodvir Hemsing; Knut Anders Mosevoll; Håkon Reikvam
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

Review 6.  Blastomycosis-Some Progress but Still Much to Learn.

Authors:  Matthew F Pullen; Jonathan D Alpern; Nathan C Bahr
Journal:  J Fungi (Basel)       Date:  2022-08-07

Review 7.  Re-drawing the Maps for Endemic Mycoses.

Authors:  Nida Ashraf; Ryan C Kubat; Victoria Poplin; Antoine A Adenis; David W Denning; Laura Wright; Orion McCotter; Ilan S Schwartz; Brendan R Jackson; Tom Chiller; Nathan C Bahr
Journal:  Mycopathologia       Date:  2020-02-10       Impact factor: 2.574

8.  Blastomycosis hospitalizations in northwestern Ontario: 2006-2015.

Authors:  S Litvinjenko; D Lunny
Journal:  Can Commun Dis Rep       Date:  2017-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.